ArticleInternational urology and nephrology2026
Comparative efficacy of kidney-sparing surgery versus radical nephroureterectomy for high-risk middle-lower ureteral urothelial carcinoma: a retrospective analysis.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUpper tract urothelial carcinoma (UTUC) is a rare and aggressive malignancy. The standard treatment, radical nephroureterectomy (RNU), may lead to renal function deterioration in high-risk patients. Kidney-sparing surgery (KSS) offers an alternative, but its efficacy in high-risk UTUC, especially for high-risk middle-lower ureteral urothelial carcinoma (UUC), is not well-established.
methodsWe conducted a retrospective analysis of 181 patients with high-risk middle-lower UUC treated between 2013 and 2023 at three hospitals in China. Patients were categorized into RNU (n = 155) and KSS (n = 26) groups. Propensity score matching (PSM) was used to balance baseline characteristics between groups. Perioperative outcomes and long-term survival were compared.
resultsAfter PSM, the KSS group showed significantly reduced surgery duration and blood loss compared to the RNU group. No significant differences were observed in transfusion rate, perioperative complications, resection margins, and hospitalization duration. In terms of prognosis, no significant differences were found in overall survival (OS), cancer-specific survival (CSS), intravesical recurrence-free survival (IVRFS), and metastasis-free survival (MFS) between the two groups post-PSM. Multivariate analysis identified T-stage as an independent risk factor for CSS.
conclusionKSS may be a feasible alternative to RNU in selected high-risk middle-lower UUC patients, with comparable long-term survival.
Indexed as
Identifiers
40545490What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.